Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer
- 1 October 2000
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 29 (2) , 59-66
- https://doi.org/10.1002/1098-2744(200010)29:2<59::aid-mc2>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CpG Islands in vertebrate genomesPublished by Elsevier ,2004
- Endocrine therapy of endometrial cancerPublished by Springer Nature ,1998
- Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Androgen responsiveness of the new human endometrial cancer cell line MFE‐296International Journal of Cancer, 1994
- Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometriumHuman Reproduction, 1992
- STRUCTURAL ORGANIZATION OF THE HUMAN ANDROGEN RECEPTOR GENEJournal of Molecular Endocrinology, 1989
- Cloning of Human Androgen Receptor Complementary DNA and Localization to the X ChromosomeScience, 1988
- CpG-rich islands and the function of DNA methylationNature, 1986
- Reactivation of an Inactive Human X Chromosome: Evidence for X Inactivation by DNA MethylationScience, 1981
- Androgenic Therapy of WomanSouthern Medical Journal, 1957